
Hanmi Pharm Co Ltd
KRX:128940

Intrinsic Value
The intrinsic value of one
Hanmi Pharm Co Ltd
stock under the Base Case scenario is
372 646.19
KRW.
Compared to the current market price of 240 000 KRW,
Hanmi Pharm Co Ltd
is
Undervalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Hanmi Pharm Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Hanmi Pharm Co Ltd
Balance Sheet Decomposition
Hanmi Pharm Co Ltd
Current Assets | 746.3B |
Cash & Short-Term Investments | 192.4B |
Receivables | 239.3B |
Other Current Assets | 314.6B |
Non-Current Assets | 1.3T |
Long-Term Investments | 176.3B |
PP&E | 822.5B |
Intangibles | 94.1B |
Other Non-Current Assets | 181.6B |
Free Cash Flow Analysis
Hanmi Pharm Co Ltd
KRW | |
Free Cash Flow | KRW |
Earnings Waterfall
Hanmi Pharm Co Ltd
Revenue
|
1.5T
KRW
|
Cost of Revenue
|
-678.5B
KRW
|
Gross Profit
|
817B
KRW
|
Operating Expenses
|
-600.9B
KRW
|
Operating Income
|
216.2B
KRW
|
Other Expenses
|
-94.9B
KRW
|
Net Income
|
121.3B
KRW
|
Profitability Score
Profitability Due Diligence
Hanmi Pharm Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Hanmi Pharm Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hanmi Pharm Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Score
Hanmi Pharm Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hanmi Pharm Co Ltd
According to Wall Street analysts, the average 1-year price target for
Hanmi Pharm Co Ltd
is 359 689.09 KRW
with a low forecast of 292 900 KRW and a high forecast of 409 500 KRW.
Dividends
Current shareholder yield for Hanmi Pharm Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Hanmi Pharm Co Ltd
stock under the Base Case scenario is
372 646.19
KRW.
Compared to the current market price of 240 000 KRW,
Hanmi Pharm Co Ltd
is
Undervalued by 36%.